Mazumdar Maitreyi, Wang Xingyan, Biswas Subrata K, Biswas Partha Pratim, Farooque Afifah, Lee Mi-Sun, North Crystal M, Afroz Sakila, Husain Nazmul, Islam Fuadul, Mostofa Md Golam, Mow Sadia, Liang Liming, Hug Christopher, Ludwig David S, Quamruzzaman Quazi, Fleisch Abby F, Christiani David C
Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Environ Epidemiol. 2024 Aug 21;8(5):e330. doi: 10.1097/EE9.0000000000000330. eCollection 2024 Oct.
Arsenic has been associated with diabetes and impaired glucose tolerance in many studies, although some reports have shown null findings.
We conducted a cross-sectional study among 300 adults in Bangladesh. Participants were randomly selected from a roster of 1800 people who previously participated in studies of arsenic and skin lesions. We measured fasting glucose and insulin levels. We assessed drinking water arsenic concentration using graphite furnace atomic absorption spectrophotometry (GF-AAS) and toenail arsenic concentration using inductively coupled mass spectrometry (ICP-MS). We ran covariant-adjusted, linear regression and spline models to examine associations of arsenic concentrations with the homeostatic model assessment of insulin resistance (HOMA-IR), a marker of insulin resistance, and HOMA of beta-cell function (HOMA-β), a marker of beta-cell function.
Among 285 participants with complete data, the median (IQR) arsenic concentration was 4.0 (6.9) μg/g in toenails and 39.0 (188.5) μg/L in drinking water. Arsenic concentrations were not associated with insulin resistance or beta-cell function. HOMA-IR was 0.67% lower and HOMA-β was 0.28% lower per µg/g increment in toenail arsenic, but these effect estimates were small, and confidence intervals crossed the null value.
Although arsenic exposure has been associated with diabetes, we found no evidence of an adverse effect on insulin resistance or beta-cell function.
尽管一些报告显示无显著结果,但在许多研究中,砷已被证实与糖尿病及糖耐量受损有关。
我们在孟加拉国的300名成年人中开展了一项横断面研究。参与者是从之前参与砷与皮肤病变研究的1800人的名单中随机选取的。我们测量了空腹血糖和胰岛素水平。我们使用石墨炉原子吸收光谱法(GF-AAS)评估饮用水中的砷浓度,使用电感耦合质谱法(ICP-MS)评估趾甲中的砷浓度。我们进行了协变量调整的线性回归和样条模型分析,以研究砷浓度与胰岛素抵抗稳态模型评估(HOMA-IR,胰岛素抵抗的一个指标)以及β细胞功能HOMA(HOMA-β,β细胞功能的一个指标)之间的关联。
在285名有完整数据的参与者中,趾甲中砷浓度的中位数(IQR)为4.0(6.9)μg/g,饮用水中砷浓度的中位数(IQR)为39.0(188.5)μg/L。砷浓度与胰岛素抵抗或β细胞功能无关。趾甲砷浓度每增加1μg/g,HOMA-IR降低0.67%,HOMA-β降低0.28%,但这些效应估计值很小,且置信区间跨越了零值。
尽管砷暴露与糖尿病有关,但我们没有发现砷对胰岛素抵抗或β细胞功能有不良影响的证据。